ESOMEPRAZOLE SANDOZ IV esomeprazole (as sodium) 40 mg powder for injection vial

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

esomeprazole sodium, Quantity: 42.56 mg (Equivalent: esomeprazole, Qty 40 mg)

Beschikbaar vanaf:

Sandoz Pty Ltd

INN (Algemene Internationale Benaming):

Esomeprazole sodium

farmaceutische vorm:

Injection, powder for

Samenstelling:

Excipient Ingredients: disodium edetate; nitrogen; sodium hydroxide

Toedieningsweg:

Intravenous, Intravenous Infusion

Eenheden in pakket:

10 vials

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

Esomeprazole Sandoz is indicated for the treatment of the following conditions:,The short-term management of Gastro-Oesophageal Reflux Disease (GORD) in patients with oesophagitis and/or severe symptoms of reflux as an alternative when oral therapy is inappropriate. ,Prevention of rebleeding in patients following therapeutic endoscopy for acute, bleeding gastric or duodenal ulcers.,Short-term management in patients requiring continued non-steroidal anti-inflammatory drug (NSAID) therapy when oral therapy is inappropriate:,_ healing of gastric ulcers associated with NSAID therapy,_ prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk

Product samenvatting:

Visual Identification: White to almost white lyophilised powder in colourless glass vial sealed with dark gray rubber stopper and flip-off cap with white button; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisatie-status:

Registered

Autorisatie datum:

2012-03-14